Jynarque
Ended Awarded Last action
- Contract number
- 36C26124N0732
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $37,742
Award facts
- Contract value 100% obligated
- $37,742.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$12,581 | |
| Original award | $50,323 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order valued at $37,742.16 to Otsuka America Pharmaceutical Inc. on June 25, 2024, with an ultimate completion date of August 26, 2024. This firm-fixed price delivery order procures Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The award was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize any set-aside designation. The place of performance is Potomac, Maryland.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s existing Blanket Purchase Agreement with the National Acquisition Center, valued at $83.3 million and scheduled through March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently procure Jynarque and supports the VA's mission of providing specialized pharmaceutical treatments to veterans nationwide. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is an established federal contractor with a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, demonstrating substantial capability in supplying complex medications to federal healthcare systems.
Quick answers
Who was awarded contract 36C26124N0732?
36C26124N0732 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 25, 2024.
How much is contract 36C26124N0732 worth?
The government has obligated $37,742 on 36C26124N0732.
Is contract 36C26124N0732 an order under another contract?
Yes. 36C26124N0732 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0732 competed?
The extent of competition for 36C26124N0732 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award